The structural gene encoding human a-Liduronidase has been assigned to chromosome 22 by using inmunologic, electrophoretic, and somatic cell hybridization techniques. Polyclonal rabbit antibodies raised against purified human low-uptake a-L-iduronidase were used to discriminate the human and murine isozymes by a sensitive immunoprecipitation assay. The human chromosome constitution of each clone was determined by cytogenetic and enzyme marker electrophoretic techniques. In 65 human (fibroblast)-mouse (RAG) somatic cell hybrids (from four independent fusions), the expression of human a-L-iduronidase was 100% concordant with the presence of human chromosome 22; the assignment was confirmed by the demonstration of the human enzyme in tertiary somatic cell hybrids containing only chromosome 22. Further verification of the gene assignment was made by detection of the human enzyme in tertiary chromosome 22 positive hybrids by Ouchterlony immunodiffusion and rocket immunoelectrophoretic experiments with polyclonal anti-human a-L-iduronidase antibodies that were monospecific for the human enzyme. Expression of human enzymatic activity in chromosome 22 positive hybrid lines was markedly reduced; for example, a tertiary hybrid (R-G21-J-15), which contained an average of 1.7 chromosome 22s per cell, only had about 15% of the activity detected in normal diploid fibroblasts. Immunologic studies suggested that the reduced expression was due to abnormal post-translational processing or aggregation (or both) of the human and murine isozymes in these hybrids. Regional assignment of the human structural gene to 22pter -* qll was accomplished by gene dosage studies using diploid human fibroblast lines that were partially monosomic or trisomic for chromosome 22.a-L-Iduronidase (a-L-iduronide iduronohydrolase, EC 3.2.1.76) is a lysosomal hydrolase required for the degradation of the mammalian glycosaminoglycans, dermatan sulfate and heparan sulfate (1-3). Fibroblast endocytosis studies have revealed that the normal human enzyme exists in two major forms, termed high uptake and low uptake (4-7). Both enzyme forms are monomeric glycoproteins whose respective physical and kinetic properties have been determined (8-12). Mucopolysaccharide storage diseases resulting from the deficient activity of this enzyme have been described in human (1, 2, 13-15), feline (16), and canine (17) species. The human disorders, Hurler, Scheie, and the Hurler-Scheie compound, have been of particular interest to geneticists because they represent phenotypically diverse diseases that presumably result from different, recessive mutations in the structural gene encoding this enzyme (15).During the past decade, a-L-iduronidase also has served as a prototype for studies of the receptor-mediated endocytosis (4-7) and maturation (18) of lysosomal enzymes. However, despite the fact that this hydrolase has occupied a central role in human cell biology and genetics, the chromosomal location of its structural gene has not been determined. In this communication,...